Author: Guest Post

2021 will result in multiple catalysts for pharmaceutical stocks Pharmaceutical stocks will be front and center in 2021, as investors look to the group to help deal with a global pandemic. Raise your hand if you were eager to see...

Whether you believe recreational marijuana should be legal or not, there is plenty of evidence supporting the use of CBD flower and hemp products for health and medical purposes. Growth companies are still hot, and many businesses that sell CBD products are....

After a year of uncertainty and financial turmoil caused by the pandemic, many are optimistic that 2021 will be much better and things will start to go back to normal, thanks largely to the rollout of vaccines in some countries....

After a year we’d rather forget, these commodity-based exchange-traded funds can help preserve your wealth Have you been wondering what 2021 will bring for your portfolio? If so, then your next question could very well be what are the best...

Investors might have thought they’d seen it all in 2020. But the stock market action was merely a preview of what’s to come in 2021. Just to take a quick look back, the market gave everyone a scare in 2020 when it...

In my high-yield investment service, the Dividend Hunter, the economic and social disruptions of 2020 forced a host of changes in my recommended investments and portfolio management guidance. As we move into 2021, I suspect investors will need to remain...

Over the years, the digital currency has gone through plenty of wild price swings. However, in recent months the price of the world’s most popular cryptocurrency has risen to well over $20,000 and it seems the price will go on...

These marijuana companies have healthy top-line growth and show a decline in cash burn Since March 2019, marijuana stocks have been fallen angels. The initial sector exuberance was replaced by concerns related to growth and sustained cash burn. In addition,...